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SUMMARY
Our objective was to compare food intake and nutritional status of Pemphigus Foliaceus patients (PG) on long term glucocorticoid
therapy to a Control Group (CG). Fourteen PG female inpatients receiving prednisone (0.33 ± 0.22mg/kg) for at least 12 months and
twelve CG subjects were submitted to nutritional evaluation, including anthropometry, urinary creatinine determination and serum
biochemical measurements, besides 48-h-based food intake records. Groups were compared by Chi-square, Mann-Whitney and “t”
tests. PG patients and CG were paired, respectively, in relation to age (24.7 ± 14.1 vs. 22.0 ± 12.0 years), body mass index (25.8 ± 6.4
vs. 24.0 ± 5.6kg/m2), daily protein intake (132.9 ± 49.8 vs. 95.2 ± 58.9g), and serum albumin (median; range) (3.8; 3.5-4.1 vs. 3.8;
3.6-5.0g/dl). However, PG patients had lower height-creatinine index (64.8 ± 17.6 vs. 90.1 ± 33.4%), and higher daily energy (3080
± 1099 vs. 2187 ± 702kcal) and carbohydrate (376.8 ± 135.8 vs. 242.0 ± 80.7g) intakes. Despite high food, protein and energy
consumption, PG patients on long term glucocorticoid therapy had lower body muscle mass than controls, while showing high body
fat stores. These findings are possibly related to combined metabolic effects of long term corticotherapy and inflammatory disease
plus corticosteroid-induced increased appetite.
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INTRODUCTION
Endemic pemphigus foliaceus (wild fire, or fogo selvagem) is a chronic
autoimmune disease histologically characterized by acantholysis and blister
formation within the epidermis5,16,20. Pemphigus foliaceus is endemic in
certain regions of Brazil and is characterized by circulating and skin
antibodies (IgG4 subclass) against desmosomal-associated antigens
(desmoglein-1), which results in local inflammatory reaction and loss of
the cohesion of keratinocytes7. In its severe, generalized, life-threatening
form there are scalp, face, trunk and limbs skin involvement, which
demands chronic glucocorticoids administration to control disease14,16.
Despite possible nutritional depletion that can result from the
generalized blisters formation and widespread skin exfoliation, no
references to nutritional evaluation on pemphigus foliaceus are available
in the literature, except a recent one which concludes that untreated
pemphigus foliaceus patients presented signs and symptoms of protein,
but not energy malnutrition1.
To our knowledge there are no specific study describing the
nutritional status of a more common condition, where a stable pemphigus
foliaceus patient is receiving chronic corticotherapy, a situation where
opposite factors that can affect nutritional status occurs, namely,
hypercatabolic and hypermetabolic effects of a chronic inflammatory
disease, and prolonged corticosteroids use, which also has catabolic
consequences, while increasing appetite and food consumption2.
The aim of the present study was to compare the nutritional status
(by anthropometry and biochemical parameters, besides food intake
records) of pemphigus foliaceus patients on long term glucocorticoid
therapy to a control group.
MATERIAL AND METHODS
The study was performed according to the Declaration of Helsinki
and all procedures were explained to participants before obtaining their
informed consent. Fourteen female patients with endemic pemphigus
foliaceus (PG, Pemphigus Group) participated in the study. They were
hospitalized at Fogo Selvagem Hospital of Uberaba-MG, Brazil, a
philanthropical institution where patients, most of them coming from
distant rural areas, abide for long periods while receiving treatment. The
Control Group (CG, n = 12) was composed of healthy female persons
paired for age and similar social, physical and constitutional
characteristics. All volunteers were submitted to clinical examination,
including blood pressure measurements, which was performed in
accordance with World Health Organization standards19.
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Pemphigus foliaceus was diagnosed on the basis of epidemiological
data, clinical signs and symptoms, and skin histopathological
examination. All patients presented the generalized form of the disease1,6,
with skin involvement of the scalp, face, trunk and limbs. None of them
had history of diabetes mellitus, high blood pressure, diarrhea,
malabsorption, or renal insufficiency, or current signs or symptoms of
acute infections. All patients were receiving immunosuppressive oral
dosage of prednisone (0.33 ± 0.22mg/kg of body weight) for at least 12
months (median = 22, range 12 to 112 months). No PG patient was on
adjunctive immunosuppressive therapy, and two were taking
phenobarbital. None of the volunteers was enrolled in regimens or taking
drugs affecting appetite.
Anthropometric evaluation was carried out by measuring weight,
height, arm circumference and triceps skin fold. Height was measured,
without shoes, to the nearest 0.1cm by using an inextensible tape. Weight
was measured in the morning, in the fasted state, after voiding and without
clothing and shoes, to the nearest 0.1kg by using portable scales. Triceps
skin fold was measured on the non-dominant arm using a Holtain®
skinfold caliper (Crymych, U.K.) after measuring a point halfway down
the arm, between the scapula acromion and the ulna olecranon. Body
mass index (BMI) was defined as weight in kilograms divided by height
in squared meters (kg/m2); BMI > 25 kg/m2 was used as criterion of
overweight or obesity10.
Dietary intake data for two consecutive days during the week was
registered from all patients and controls. Basically, both PG and CG
groups consumed a diet based on typical rice and beans admixture, plus
fruits, vegetables and some meat, five to sixfold a day. To accurately
estimate the quantities of consumed nutrients, kitchen utensils (plates,
glasses, and spoons) and containers of known capacity were used. The
methods of food preparation were also known by a registered dietitian,
which calculated the intake of energy, proteins, lipids, carbohydrates,
sodium, calcium, phosphorus, magnesium, and potassium, by using a
PC computer program. The food tables used in the program are from the
U.S. Department of Agriculture, Handbook # 8, 1980, with some regional
foods added12.
Energy intake percentage was calculated according to the formula:
actual energy intake x 100/basal energy expenditure, determined by
Harris-Benedict formula13. All hospitalized patients were able to stand
up and walk around at a hospital outdoor area set aside for recreation;
most of them were engaged in diurnal light activities, such as watching
TV or playing cards or domino. CG persons were engaged in free-living
daily light physical activities.
Fasting blood was collected from a peripheral vein of each patient
and control subject for serum sodium, potassium, calcium, urea, albumin
and total protein measurements, in addition to hemoglobin and
erythrocyte sedimentation rate (ESR) determinations. Creatinine excreted
in urine during 48 hours, which correlates with body muscle mass9,18,
was measured and the results expressed in mg/day, on a 24-h basis, the
same occurring with urinary urea excretion.
Continuous variables with normal distribution are expressed as mean
± standard deviation; in this case the comparison between groups were
performed using the “t” Student test. Mann-Whitney test was used for
variables with non-normal distribution, which are expressed as median
and range. The Fisher exact test was used to compare frequency
distributions between groups. A p value < 0.05 was considered statistically
significant.
RESULTS
PG patients and CG persons were paired, respectively, in relation to
age (24.7 ± 14.1 vs. 22.0 ± 12.0 years), ethnic origin, with non-white
color predominance (66.7 vs. 57.2%), height (147.5 ± 0.12 vs. 154.3 ±
0.07cm), body mass index (25.8 ± 6.4 vs. 24.0 ± 5.6kg/m2), and other
anthropometric measurements (Table 1).
Overweight or obesity was diagnosed in five PG patients (42%) and
seven (50%) CG persons. Despite similar diastolic blood pressure between
PG (74.6 ± 12.8mmHg) and CG (71.2 ± 6.4mmHg) groups, pemphigus
foliaceus patients showed higher systolic blood pressure (123.2 ± 18.9 vs.
108.7 ± 8.3mmHg) and heart rate (90.1 ± 16.1 vs. 75.4 ± 5.8bpm).
Table 2
Daily dietary intake of controls subjects and pemphigus foliaceus
patients on long term glucocorticoid therapy at Fogo Selvagem
Hospital of Uberaba-MG, Brazil
Parameters Pemphigus Controls
Energy (kcal)* 3079.97 ± 1099.6 2187.3 ± 701.8
Energy (% of BMR)* 231.87 ± 80.46 163.86 ± 59.87
Protein (g) 132.95 ± 49.82 95.16 ± 28.1
Lipids (g) 114.42 ± 40.52 93.56 ± 28.1
Carbohydrates (g)* 376.83 ± 135.8 242.04 ± 80.75
Calcium (mg) * 1202.4 ± 443.8 834.87 ± 321.5
Sodium (mg) 2702.71 ± 994.8 2331.66 ± 880.3
Potassium (mg) 3645.5 ± 1551.7 3787.0 ± 1593.0
Phosphorus (mg) 1820.1 ±695.9 1350.3 ± 714.1
Magnesium (mg) 111.6 ± 43.7 133.9 ± 71.9
BMR = basal metabolic rate, determined by Harris-Benedict formula;
* p < 0.05
Table 1
Anthropometric and laboratorial parameters in control persons and
pemphigus foliaceus patients on long term glucocorticoid therapy at
Fogo Selvagem Hospital of Uberaba-MG, Brazil
Parameters Pemphigus Controls
Weight (kg) 57.2 ± 13.7 57.6 ± 15.5
Height (cm) 147.5 ± 0.12 154.3 ± 0.07
Body mass index (kg/m2 ) 25.84 ± 6.38 24.03 ± 5.6
Arm circumference (cm) 28.6 ± 4.5 27.3 ± 4.0
Triceps skinfold (mm) 23.8 ± 7.1 25.3 ± 9.5
Serum total proteins (g/dl) 7.05 ± 0.45 7.12 ± 0.50
Serum albumin (g/dl) 3.8 (3.5 – 4.1) 3.8 (3.6 – 5.0)
Hemoglobin (g/dl) 13.1 ± 1.3 13.7 ± 0.9
Erythrocyte sedimentation* 44 (9 – 87) 8 (2 – 30)
Height-creatinine index (%)* 64.8 ± 17.6 90.1 ± 23.4
* p < 0.05
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PG and CG groups showed similar blood hemoglobin (13.1 ± 1.3
vs. 13.7 ± 0.9g/dl), and serum total proteins (7.05 ± 0.45 vs. 7.12 ±
0.50g/dl), albumin (median; range) (3.8; 3.5-41 vs. 3.8; 3.6-5.0g/dl),
urea (21.5 ± 9.3 vs. 22.3 ± 7.1mg/dl), and calcium (8.5 ± 0.6 vs. 8.6 ±
1.0mg/dl). Despite higher serum sodium (140.9 ± 1.6 vs. 139.3 ±
1.9mEq/l) and erythrocyte sedimentation rate (44; 9-87 vs. 8; 2-30), PG
patients had lower values of serum potassium (3.21 ± 0.69 vs. 3.73 ±
0.26mEq/l) and height-creatinine index (64.8 ± 17.6 vs. 90.1 ± 33.4%).
CG and PG showed similar urinary urea excretion, respectively 13.4 ±
3.7 and 11.4 ± 3.4g/day.
PG patients ingested greater daily amount of food (Table 2), as
documented by higher energy consumption (3079.9 ± 1099.6 vs. 2187.3
± 701.8kcal), carbohydrate (376.8 ± 135.8 vs. 242.0 ± 80.7g) and calcium
(1202.4 ± 443.8 vs. 834.9 ± 321.5g). Sodium, potassium, phosphorus
and magnesium intakes were similar between groups (Table 2).
DISCUSSION
Notwithstanding similar demographic and anthropometric
characteristics, and higher energy, carbohydrate, calcium, and other food
constituent’s intake, pemphigus foliaceus patients on long term
glucocorticoid therapy showed lower values of height-creatinine index
than controls. As urinary creatinine determination is a well grounded
method of muscle mass measurement10,18, one can conclude that, despite
above average triceps skin fold documenting increased body fat reserves9,
these patients also have decreased body skeletal muscle. Our findings
suggest that these differences can not be attributed to insufficient protein
intake or to increased losses of urinary nitrogen. Rather, as all patients
had pemphigus foliaceus generalized form, it is possible that increased
protein losses associated with skin cell desquamation might have such
effect in body protein status.
Normal serum albumin levels of our cases differ from those of
BARRAVIERA et al., which documented hypoalbuminemia in patients
with disseminated form of pemphigus foliaceus1. Nonetheless, serum
albumin is not a good nutritional index in chronic inflammation, because
serum albumin levels are largely determined by nonnutritional factors
such as cytokine-induced reprioritization of hepatic protein synthesis,
catabolism, dilution, and third-space losses13. In addition, besides a
possible role of increased hepatic albumin synthesis induced by
corticosteroids1,8, normal serum albumin levels in our PG patients can
be ascribed to high protein and energy intake.
Calcium intake of most PG patients was adequate to meet normal
person’s requirements. However, as supraphysiological concentrations
of glucocorticoids inhibit bone formation and reduce intestinal calcium
absorption, these patients may be under increased risk of osteoporosis4.
In addition, according to hypercortisolism state, and despite similar
sodium and potassium intakes, pemphigus patients showed higher sodium
and lower potassium serum levels.
Decreased physical activity often occurs in chronic ill patients15 and,
as documented in the present study, long term glucocorticoid therapy is
associated with high energy intake, which could predispose PG patients
to complications such as obesity and glucose intolerance. Moreover,
oral cortisol increases blood pressure in a dose-dependent fashion,
phenomenon accompanied by a significant sodium retention and volume
expansion3. Indeed, PG patients showed higher systolic blood pressure
than controls. Nonetheless, despite increased body mass index in PG
patients might be ascribed to increased energy consumption and decreased
physical activity, high overweight and obesity frequencies in control
group is not apparent and could be attributed to low social rank, where
obesity prevalence is raising, or to some unidentifiable bias in control
group choice.
Prolonged systemic high corticosteroids administration is crucial
for pemphigus control, but it is often associated with numerous side
effects2, 11, including increased body fat accumulation and decreased
muscle mass17. Therefore, the present study showed that, despite high
food, protein and energy consumption, pemphigus foliaceus patients
on long term glucocorticoid therapy had lower body muscle mass than
controls, while showing high body fat stores. These findings are
possibly related to combined metabolic effects of chronic corticotherapy
and inflammatory disease plus corticosteroid-induced increased
appetite, besides decreased physical activity. A rational diet therapy
approach would be to prescribe high-protein, low fat, low sodium and
low carbohydrates diets, with attention paid to calcium and potassium
levels.
RESUMO
Avaliação do estado nutricional de pacientes com pênfigo foliáceo
sob corticoterapia prolongada
O objetivo deste trabalho foi comparar o estado nutricional e dados
de ingestão alimentar de pacientes com Pênfigo Foliáceo (PF, n=14) sob
corticoterapia prolongada (prednisona, 0,33 ± 0,22mg/kg/dia há mais
de 12 meses) com um Grupo Controle (GC, n=12). A avaliação constou
de inquérito alimentar de 48 horas, antropometria e determinação de
creatinina urinária de 24h e albumina sérica. Os grupos PF e GC foram
pareados, respectivamente, quanto à idade (24,7 ± 14,1 vs 22,0 ± 12,0
anos), índice de massa corporal (25,8 ± 6,4 vs 24,0 ± 5,6kg/m2), ingestão
diária de proteína (132,9 ± 49,8 vs 95,2 ± 58,9g) e albumina sérica
(mediana;faixa de variação) (3,8;3,5-4,1 vs 3,8;3,6-5,0g/dl). Pacientes
com pênfigo apresentaram menor índice creatinina-altura (64,8 ± 17,6
vs 90,1 ± 33,4%) e maior ingestão de energia (3080 ± 1099 vs 2187 ±
702kcal/dia) e carboidratos (376,8 ± 135,8 vs 242,0 ± 80,7g/dia). Apesar
do maior consumo de alimentos, os pacientes com pênfigo apresentaram
menor massa muscular que os controles, achados possivelmente
relacionados ao aumento do apetite e efeitos metabólicos combinados
da corticoterapia e da doença inflamatória crônica.
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